Christopher Jones, PhD

New England CEPAC Members

Network Director, Venture Investments | University of Vermont Health Network

Chris Jones, PhD is a trained health economist and venture capitalist who is known for thinking outside the box. Since 2017 he has served as Network Director of Venture Investments across the University of Vermont’s 8-hospital Health Network. Prior to this role Chris was Director of the Global Health Economics Unit at the University of Vermont. His early work includes developing the first personalized fertility calculator in the 1990s with a focus on cost-effective in vitro fertilization (IVF), the results of which are published in the New England Journal of Medicine. At the University of Vermont College of Medicine, Chris created an award-winning adherence tool called trUStr, which uses artificial intelligence (AI) to determine the most effective words of adherence encouragement using text messaging. His work in Twitter bot detection helped form Vermont policy changes concerning e-cigarette advertisement to children and consequent taxation.

A member of the National Venture Capital Association, XConomy’s Napa and Boston Summits, the Strategic Ventures Group of Health Systems Investors, Inova’s Discovery Group, Springboard’s Life Sciences Group, the LSX Conference, and a platform speaker at both the upcoming World Healthcare Congress and International Society for Pharmacoeconomics and Outcomes Research; Chris is active across the health ventures industry. Chris is also a judge for France’s New Technology Venture Accelerator (NETVA), and for a number of non-profit awarding agencies. In England, Chris has worked as a health economist for the Guideline Development Group of the National Institutes for Health and Clinical Excellence (NICE). For 2019, Chris will serve as affiliate associate professor and pharmapreneur in residence in the University of Maryland School of Pharmacy.

Chris is a graduate of the University of Michigan and Oxford University (Christ Church), with an MSc in biology and doctorate in health economics, the latter funded by the Bertarelli Foundation. His post-doctoral fellowships are from University College London and Johns Hopkins University.